Frequently Asked


Explore our frequently asked questions (FAQs) for answers to common inquiries, such as product availability, technically capabilities, service, and technical support.

Don’t see what you’re looking for? Email us at Let us know if there’s a topic or product that you’d like further information about.

Product Availability

Yes. The Pure-Vu® System is commercially available in various regions of the United States. With a commitment to provide dedicated support to customers as they integrate the System into their facilities, MOTUSGI is currently limiting its focus and resources to select geographic regions.

The Pure-Vu® System received CE Mark in February 2018; however, MOTUSGI efforts are currently focused on commercialization in the United States. Commercial activities in Europe are expected to start in 2025.

MOTUSGI is currently doing a limited launch with a direct sales force in the United States. The company is open to work with experienced distributors in the United States.

Capabilities & Clinical Evidence

Yes. Pure-Vu® can be used to clear the field of view in both an EGD procedure and a colonoscopy.

A number of major medical centers across the United States are currently using the Pure-Vu® System to improve visualization in both their EGD and colonoscopy procedures. For more information, please make a request through the "Where Here to Help" section at the bottom of this page.

At present, MOTUSGIis not actively looking for additional clinical trial sites.
However, if you have interest in participating in an upcoming clinical trial, please contact a MOTUSGI via the "We Are Here to Help" section at the bottom of this page. The clinical team assesses clinical needs and identifies appropriate partners for each study.

In three multi-center studies and one single-center study, patients presenting with an inadequately prepped colon (as determined by the Boston Bowel Preparation Scale) became adequately prepped for colonoscopy after cleansing with the Pure-Vu® System.

BBPS Rating Before and After the
Use of the Pure-Vu® System
BBPS Rating Before and After the Use of the Pure-Vu System

Technical Support

There have been no perforations reported with either the Gen 3 or current Gen 4 versions of the system.

Perforations are identified as precautions within the Pure-Vu® IFU and are consistent with the associated risk for a standard colonoscopy.

In cleansing mode, the Pure-Vu® System has an air flow of 0 cc in low mode, 1100 cc/min in medium, and 1350 cc/min in high mode; and the irrigation water flow has a maximum flow of 645 cc/min for all settings, but on average runs at 530 cc/min.

The amount of fluid used to cleanse the colon can fluctuate based on the level of dirtiness. However, on average, procedures use ~1L of fluid.

No. The endoscope working channel remains patent so standard therapeutic procedure can be performed.

Yes. Use of the Pure-Vu System does not change your ability to insufflate with CO2. The majority of insufflation in a Pure-Vu procedure is CO2. The air emitted from the Pure-Vu device represents only a fraction of the gas in the lumen. Rapid absorption of CO2 should still take place during and after the procedure. I have not had physicians note discomfort or delay from the air in procedures.

Yes. Physicians have found benefit and success with utilizing the Pure-Vu® System during the water exchange and water immersion techniques. The latest version of the Pure Vu EVS system has a new "Fluid Only" mode that facilitates flooding the colon and with it's suction capabilities can rapidly remove fluid at the completion of the procedure.

MOTUSGI is committed to assisting its customers before, during and after Pure-Vu® System procedures. In addition to a robust inservice program for physicians, nurses and technical staff, MOTUSGI provides hands-on support until customers are comfortable and proficient users of the System. Additionally, an intuitive Helpful Hints guide and instructive video are available for ongoing loading and unloading reference.

We're here to help